In this article

本文中

REGN

再生元制药（Regeneron Pharmaceuticals）

Follow your favorite stocks

关注你喜爱的股票

CREATE FREE ACCOUNT

创建免费账户

A view of the 23andMe headquarters in Sunnyvale, California, on March 25, 2025.

2025年3月25日，加利福尼亚州桑尼维尔市23andMe总部的视图。

Tayfun Coskun | Anadolu | Getty Images

塔伊丰·科斯昆 | 安纳多卢 | 盖蒂图片社

Regeneron Pharmaceuticals

再生元制药公司

on Monday announced it will acquire 'substantially all' of 23andMe's assets for $256 million.

周一宣布将以 2.56 亿美元收购 23andMe 的“几乎所有”资产。

The drugmaker participated in a bankruptcy auction for 23andMe, a once high-flying genetic testing company that

制药商参与了23andMe的破产拍卖，这是一家曾经备受瞩目的基因检测公司，

filed for for Chapter 11

申请了第11章破产保护

bankruptcy protection in March. Regeneron is buying 23andMe's Personal Genome Service, Total Health and Research Services business lines, according to

3月申请破产保护。据称，再生元正在收购23andMe的个人基因组服务、整体健康和研究服务业务线。

a release

一个版本

.

。

'We believe we can help 23andMe deliver and build upon its mission to help people learn about their own DNA and how to improve their personal health, while furthering Regeneron's efforts to improve the health and wellness of many,' Dr. George Yancopoulos, Regeneron's president, said in a statement.

乔治·扬科普洛斯博士在一份声明中表示：“我们相信，我们可以帮助23andMe实现并建立其使命，即帮助人们了解自己的DNA以及如何改善个人健康，同时也进一步推动Regeneron改善许多人的健康和福祉的努力。”

Regeneron will not buy the company's telehealth subsidiary, Lemonaid Health, which 23andMe had acquired for around

再生元将不会购买该公司的远程医疗子公司Lemonaid Health，23andMe此前以大约

$400 million

4亿美元

in 2021. Lemonaid Health will be shut down, but Regeneron has offered to employ all staffers of the acquired business units, according to the release.

2021年，Lemonaid Health 将被关闭，但根据新闻稿，Regeneron 已提出愿意雇佣被收购业务部门的所有员工。

The deal is still subject to approval by the U.S. Bankruptcy Court for the Eastern District of Missouri. Pending approval, it's expected to close in the third quarter of this year, according to the release.

该交易仍有待美国密苏里东区破产法院的批准。根据新闻稿，预计在获得批准后，交易将在今年第三季度完成。

23andMe rocketed into the mainstream because of its at-home DNA testing kits that gave customers insight into their family histories and genetic profiles. The five-time

23andMe因其在家DNA测试套件而迅速成为主流，这些套件让客户了解他们的家族历史和基因概况。这个五次...

CNBC Disruptor 50

CNBC颠覆者50强

company

公司

went public

上市

in 2021 via a merger with a special purpose acquisition company. At its peak, 23andMe was valued at around $6 billion.

2021年通过与特殊目的收购公司合并上市。在巅峰时期，23andMe的估值约为60亿美元。

The company struggled to generate recurring revenue and stand up viable research and therapeutics businesses after going public, and it's been plagued by privacy concerns since

公司上市后，一直在努力创收经常性收入，并建立可行的研究和治疗业务，而且自那以后一直受到隐私问题的困扰。

hackers accessed the information

黑客访问了这些信息

of nearly 7 million customers in 2023.

2023年近700万客户。

In its bankruptcy proceedings, 23andMe required all bidders to comply with its privacy policies, and a court-appointed, independent 'Consumer Privacy Ombudsman' will assess the deal, the companies said.

公司表示，在其破产程序中，23andMe要求所有竞标者遵守其隐私政策，并由法院任命的独立“消费者隐私监察员”对交易进行评估。

Several lawmakers and officials, including the

包括几位立法者和官员在内的

Federal Trade Commission

联邦贸易委员会

, had expressed concerns about the safety of consumers' genetic data through 23andMe's sale process. The privacy ombudsman will present a report on the acquisition to the court by June 10.

，对通过23andMe销售过程中的消费者基因数据安全性表示担忧。隐私监管员将于6月10日之前向法院提交一份关于此次收购的报告。

'We are pleased to have reached a transaction that maximizes the value of the business and enables the mission of 23andMe to live on, while maintaining critical protections around customer privacy, choice and consent with respect to their genetic data,' Mark Jensen, 23andMe's board chair, said in a statement..

“我们很高兴达成了这项交易，它最大化了公司的价值，使23andMe的使命得以延续，同时在客户对其基因数据的隐私、选择和同意方面保持了关键的保护，”23andMe董事会主席马克·詹森在一份声明中表示。

WATCH:

观看：

Inside the fall of 23andMe

23andMe的衰落内幕

watch now

立即观看

VIDEO

视频

8:45

8点45分

08:45

08:45

The rise and fall of 23andMe

23andMe的兴衰

Tech

技术